| 查看: 637 | 回复: 7 | ||
| 【奖励】 本帖被评价4次，作者ludasheng-1增加金币 3.5 个 | ||
| 当前主题已经存档。 | ||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | ||
[资源]
Cancer Proteomics: From Bench to Bedside (Cancer Drug Discovery and Development)
|
||
 Cancer Proteomics: From Bench to Bedside (Cancer Drug Discovery and Development) By Sayed S. Daoud Publisher: Humana Press Number Of Pages: 300 Publication Date: 2007-11-13 ISBN-10 / ASIN: 1588298582 ISBN-13 / EAN: 9781588298584 Binding: Hardcover This book provides the reader with broad perspectives and breadth of knowledge on current topics related to the use of proteomic strategies in cancer therapy as well as anticipated challenges that may arise from its application in daily practice. The book is divided into 4 parts. The first part begins with the current technologies used in proteomics that allow for protein profiling and for the identification of druggable targets in human samples. Mass spectrometry based protein characterization and protein microarrays hold great promise of predicting response to specific drugs in cancer therapy. The second part deals with the use proteomics in cell signaling. At the present, the pharmaceutical and biotechnology industries have many potentially useful small molecule inhibitors of many pathways important in cancer that have yet to be taken to clinical trials. Understanding protein-protein interaction and posttranslational modifications through proteomics will likely make it much more feasible to do effective clinical trials of these small molecules alone and in combinations to overcome drug resistance and improve patient care. The third part of the book moves from signaling to actual clinical applications of proteomics in cancer therapy. Case studies in may tumor types are provided to show the feasibility of generating the critical information needed to individualization of therapy in cancer patients. The final part of the book provides in depth information on annotating the human proteome and the role of Food and Drug Administration (FDA) in regulating the use of proteomics in cancer therapy. To functionally annotate the human proteome, the Swiss Institute for Bioinformatics (SIB) and the European Bioinformatics Institute (EBI) initiated a major effort to distribute to the scientific community highly integrated information on human protein sequences. This initiative, which is called the Human Proteomics Initiative (HPI) aims to provide for each known human protein a wealth of information that include the description of its function, domain and protein family classification, subcellular location, posttranslational modifications, variants and similarities to other proteins. Integration of bioinformatics into clinical application of proteomics in cancer therapy is outlined as well as regulations and policy of commercial application of proteomics in patient care. Link: http://rapidshare.com/files/79603386/asd_Cancer_Proteomics.rar http://www.megaupload.com/?d=TSQS7G6L http://w15.easy-share.com/13439551.html http://depositfiles.com/files/2867982 http://rapidshare.com/files/7968 ... .bioXplorer.com.rar [search]Cancer Proteomics[/search] |
回复此楼» 猜你喜欢
澳大利亚 Murdoch University 全奖博士招生（3个名额）地质化工冶金领域
已经有52人回复
-
我的国基提前知道中了，可是同事的操作让我实在接受不了，怎么会有这样的人
已经有15人回复
-
欢迎发来filecode的Mz6后的代码验证其规律
已经有29人回复
-
关于Filecode分析方法
已经有12人回复
-
咱们一起用铁证分析2026国家社科基金中标与否
已经有11人回复
-
小木虫上这么多卖论文的，真有人买论文么？感觉没必要啊
已经有10人回复
-
阿姨
已经有4人回复
-
一作与独作在应聘高校教师时区别大吗
已经有4人回复
-
静等基金结果
已经有21人回复
-
FileCode能看出啥？
已经有28人回复
5楼2008-02-21 21:28:54
2楼2007-12-30 05:54:04
3楼2007-12-30 09:07:34
4楼2007-12-30 09:30:31
